65
Aclaris Therapeutics, Inc. raises $80M under Reg D
Company raise · Closed · WAYNE, PA · Form D filed 2024-12-04
$50M+ raiseFirst raise on EDGARPlacement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Andrew Schiff | Director |
| Joseph Monahan | Executive Officer |
| Anand Mehra | Director |
| Hugh Davis | Executive Officer, Director |
| James Loerop | Executive Officer |
| Neal Walker | Executive Officer, Director |
| Vincent Milano | Director |
| William Humphries | Director |
| Kevin Balthaser | Executive Officer |
| Christopher Molineaux | Director |
| Maxine Gowen | Director |
Signed by Kevin Balthaser, Chief Financial Officer.
Placement agents / sales compensation: Cantor Fitzgerald & Co.; Leerink Partners LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.